<DOC>
	<DOCNO>NCT01814566</DOCNO>
	<brief_summary>This study advocate Institute Basic Research Clinical Medicine , China Academy Chinese Medical Sciences January 2013 . It fund China major scientific technological specialize project 'significant new formulation new drug ' . DanshenDuofensuanyan kind Chinese Medicine injection use treat coronary heart disease angina pectoris many Chinese hospital . The purpose study determine adverse drug event adverse drug reaction large sample size 30,000 patient .</brief_summary>
	<brief_title>Safety Study DanshenDuofensuanyan ( Chinese Medicine Injection ) Used Hospitals China</brief_title>
	<detailed_description>It common Chinese Medicine Injection use hospital mainland China . However safety problem rise recent year . There could many uncertain factor influence Chinese Medicine Injection clinical practice . In order ensure safety public drug use lower drug-induced risk , registry study DanshenDuofensuanyan injection safety surveillance 30000 patient conduct Jan.2013 Dec.2015 . Eligibility criterion Patients use DanshenDuofensuanyan injection select hospital .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<criteria>Patients use DanshenDuofensuanyan injection 2013 2014</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>